2016
DOI: 10.1039/c5ra19673f
|View full text |Cite
|
Sign up to set email alerts
|

A structure guided drug-discovery approach towards identification of Plasmodium inhibitors

Abstract: This article provides a comprehensive review of inhibitors from natural, semisynthetic or synthetic sources against key targets ofPlasmodium falciparum.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
7
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 22 publications
(7 citation statements)
references
References 207 publications
0
7
0
Order By: Relevance
“…Inhibition of PfPNP results in parasite death through purine starvation, since P. falciparum is a purine auxotroph due to lack of the de novo purine biosynthetic pathway [41]. PfPNP catalyzes inosine phosphorolysis into ribose-1-phosphate and hypoxanthine, the primary purine substrate for the salvage pathway [53]. erefore, we considered PfPNP as a molecular target of the proposed synthesized compounds.…”
Section: Antiprotozoal Activitymentioning
confidence: 99%
“…Inhibition of PfPNP results in parasite death through purine starvation, since P. falciparum is a purine auxotroph due to lack of the de novo purine biosynthetic pathway [41]. PfPNP catalyzes inosine phosphorolysis into ribose-1-phosphate and hypoxanthine, the primary purine substrate for the salvage pathway [53]. erefore, we considered PfPNP as a molecular target of the proposed synthesized compounds.…”
Section: Antiprotozoal Activitymentioning
confidence: 99%
“…However, the emergence of CQ‐resistance in the 1960s paved the way for the development of artemisinin combination therapy (ACT), worldwide (Beteck, Smit, Haynes, & N’Da, 2014; Dondorp et al., 2010). Unfortunately, the development of resistance to ACTs in Southeast Asia along with the lack of effective vaccine has called for urgent efforts to enrich the chemical libraries with new scaffolds with potent anti‐plasmodial activities and low incidence of resistance (Aneja, Kumar, Jairajpuri, & Abid, 2016; Dondorp et al., 2009; Gobbi et al., 2016; Leang et al., 2015).…”
Section: Introductionmentioning
confidence: 99%
“…Chemical compounds with a low biological toxicity stemming from natural products can be obtained from a wide range of sources, 14,15 and are being used as lead compounds in the preparation of safe and low toxicity hemostatic drugs. In our previous studies, 16,17 we evaluated the activity of cinnamic acid amide derivatives synthesized by sulfa drug 2-aminothiazole with cinnamic acid compounds.…”
Section: Introductionmentioning
confidence: 99%